DNA vaccines for biodefence

Advanced Drug Delivery Reviews

Volumn 57, Issue 9, 2005, Pages 1343-1361

  Garmory, Helen S ^a   Perkins, Stuart D ^a   Phillpotts, Robert J ^a   Titball, Richard W ^a,b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Bacteria; Carriers; Co stimulatory molecules; Delivery; Immunity; Regimens; Targeting; Viruses

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; BIOTECHNOLOGY; DNA; IMMUNOLOGY;

BIODEFENSE; BROAD SPECTRUM; DNA VACCINES; IMMUNE RESPONSES;

VACCINES;

ALPHAVIRUS VACCINE; ANTHRAX VACCINE; ARENAVIRUS VACCINE; BACTERIAL VACCINE; BUPIVACAINE; CLOSTRIDIUM BOTULINUM VACCINE; CREATINE KINASE; DNA VACCINE; EBOLA VACCINE; FILOVIRUS VACCINE; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; LIVE VACCINE; MARBURG VIRUS VACCINE; PLASMID DNA; POXVIRUS VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE; VENEZUELAN EQUINE ENCEPHALITIS VACCINE; VIRUS VACCINE; VIRUS VECTOR; VITAMIN D;

BACTERIUM; CELLULAR IMMUNITY; CLINICAL TRIAL; DNA VECTOR; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE GUN; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; INFECTION; MICROENCAPSULATION; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VACCINIA; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; BACTERIAL VACCINES; BIOLOGICAL WARFARE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; TECHNOLOGY, PHARMACEUTICAL; VACCINES, DNA; VIRAL VACCINES; VIRUS DISEASES;

EID: 20344370230     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.01.013     Document Type: Review

References (154)

1. R.J. Whitley Smallpox: a potential agent of bioterrorism Antivir. Res. 57 2003 7 12
2. J.C. Pile, J.D. Malone, E.M. Eitzen, and A.M. Friedlander Anthrax as a potential biological warfare agent Arch. Intern. Med. 158 1998 429 434
3. J.G. Sotos Botulinum toxin in biowarfare JAMA 285 2001 2716
4. H.L. Davis Plasmid DNA expression systems for the purpose of immunization Curr. Opin. Biotechnol. 8 1997 635 646
5. A.K. Sharma, and G.K. Khuller DNA vaccines: future strategies and relevance to intracellular pathogens Immunol. Cell Biol. 79 2001 537 546
6. M.A. Chattergoon, J.J. Kim, J.S. Yang, T.M. Robinson, D.J. Lee, T. Dentchev, D.M. Wilson, V. Ayyavoo, and D.B. Weiner Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis Nat. Biotechnol. 18 2000 974 979
7. S. Sasaki, R.R. Amara, A.E. Oran, J.M. Smith, and H.L. Robinson Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases Nat. Biotechnol. 19 2001 543 547
8. T.W. Kim, C.F. Hung, M. Ling, J. Juang, L. He, J.M. Hardwick, S. Kumar, and T.C. Wu Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins J. Clin. Invest. 112 2003 109 117
9. W.W. Leitner, and N.P. Restifo DNA vaccines and apoptosis: to kill or not to kill? J. Clin. Invest. 112 2003 22 24
10. M. Kozak At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells J. Mol. Biol. 196 1987 947 950
11. H.S. Garmory, K.A. Brown, and R.W. Titball DNA vaccines: improving expression of antigens Genet. Vaccines Ther. 1 2003 2
12. L. Cheng, P.R. Ziegelhoffer, and N.S. Yang In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment Proc. Natl. Acad. Sci. U. S. A. 90 1993 4455 4459
13. M. Manthorpe, F. Cornefert-Jensen, J. Hartikka, J. Felgner, A. Rundell, M. Margalith, and V. Dwarki Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice Hum. Gene Ther. 4 1993 419 431
14. A.H. Lee, Y.S. Suh, J.H. Sung, S.H. Yang, and Y.C. Sung Comparison of various expression plasmids for the induction of immune response by DNA immunization Mol. Cells 7 1997 495 501
15. D. Loirat, Z. Li, M. Mancini, P. Tiollais, D. Paulin, and M.L. Michel Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses Virology 260 1999 74 83
16. T.A. Galvin, J. Muller, and A.S. Khan Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina Vaccine 18 2000 2566 2583
17. C. Tucker, M. Endo, I. Hirono, and T. Aoki Assessment of DNA vaccine potential for juvenile Japanese flounder Paralichthys olivaceus, through the introduction of reporter genes by particle bombardment and histopathology Vaccine 19 2000 801 809
18. D.L. Suarez, and S. Schultz-Cherry The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model Avian Dis. 44 2000 861 868
19. A.M. Watts, R.K. Bright, and R.C. Kennedy DNA cancer vaccination strategies target SV40 large tumour antigen in a murine experimental metastasis model Dev. Biol. (Basel) 104 2000 143 147
20. Z.L. Xu, H. Mizuguchi, A. Ishii-Watabe, E. Uchida, T. Mayumi, and T. Hayakawa Optimization of transcriptional regulatory elements for constructing plasmid vectors Gene 272 2001 149 156
21. A. Garapin, L. Ma, P. Pescher, M. Lagranderie, and G. Marchal Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins Vaccine 19 2001 2830 2841
22. M. Kwissa, K. von Kampen, R. Zurbriggen, R. Gluck, J. Reimann, and R. Schirmbeck Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control Vaccine 18 2000 2337 2344
23. R.J. Bartlett, S.L. Secore, J.T. Singer, M. Bodo, K. Sharma, and C. Ricordi Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: comparison of human creatine kinase and CMV promoter expression levels in vivo Cell Transplant. 5 1996 411 419
24. J.R. Gebhard, J. Zhu, X. Cao, J. Minnick, and B.A. Araneo DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes Vaccine 18 2000 1837 1846
25. K. Itai, D. Sawamura, X. Meng, and I. Hashimoto Keratinocyte gene therapy: inducible promoters and in vivo control of transgene expression Clin. Exp. Dermatol. 26 2001 531 535
26. C. Rush, T. Mitchell, and P. Garside Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways J. Immunol. 169 2002 4951 4960
27. B.S. Chapman, R.M. Thayer, K.A. Vincent, and N.L. Haigwood Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells Nucleic Acids Res. 19 1991 3979 3986
28. T. Ikemura Codon usage and tRNA content in unicellular and multicellular organisms Mol. Biol. Evol. 2 1985 13 34
29. M. Uchijima, A. Yoshida, T. Nagata, and Y. Koide Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium J. Immunol. 161 1998 5594 5599
30. S. Andre, B. Seed, J. Eberle, W. Schraut, A. Bultmann, and J. Haas Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage J. Virol. 72 1998 1497 1503
31. L. Vinner, H.V. Nielsen, K. Bryder, S. Corbet, C. Nielsen, and A. Fomsgaard Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons Vaccine 17 1999 2166 2175
32. L. Deml, A. Bojak, S. Steck, M. Graf, J. Wild, R. Schirmbeck, H. Wolf, and R. Wagner Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein J. Virol. 75 2001 10991 11001
33. D.L. Narum, S. Kumar, W.O. Rogers, S.R. Fuhrmann, H. Liang, M. Oakley, A. Taye, B.K. Sim, and S.L. Hoffman Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice Infect. Immun. 69 2001 7250 7253
34. R. Stratford, G. Douce, L. Zhang-Barber, N. Fairweather, J. Eskola, and G. Dougan Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus Vaccine 19 2000 810 815
35. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R. Teasdale, G.A. Koretzky, and D.M. Klinman CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 1995 546 549
36. D.M. Klinman, A.K. Yi, S.L. Beaucage, J. Conover, and A.M. Krieg CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma Proc. Natl. Acad. Sci. U. S. A. 93 1996 2879 2883
37. D.M. Klinman, G. Yamshchikov, and Y. Ishigatsubo Contribution of CpG motifs to the immunogenicity of DNA vaccines J. Immunol. 158 1997 3635 3639
38. A.M. Krieg, A.K. Yi, J. Schorr, and H.L. Davis The role of CpG dinucleotides in DNA vaccines Trends Microbiol. 6 1998 23 27
39. K.R. Porter, T.J. Kochel, S.J. Wu, K. Raviprakash, I. Phillips, and C.G. Hayes Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses Arch. Virol. 143 1998 997 1003
40. R. Weeratna, C.L. Brazolot Millan, A.M. Krieg, and H.L. Davis Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides Antisense Nucleic Acid Drug Dev. 8 1998 351 356
41. L.G. Payne, D.H. Fuller, and J.R. Haynes Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma Curr. Opin. Mol. Ther. 4 2002 459 466
42. S. Yamamoto, T. Yamamoto, S. Shimada, E. Kuramoto, O. Yano, T. Kataoka, and T. Tokunaga DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth Microbiol. Immunol. 36 1992 983 997
43. G. Hartmann, and A.M. Krieg Mechanism and function of a newly identified CpG DNA motif in human primary B cells J. Immunol. 164 2000 944 953
44. C.P. Locher, S.A. Witt, B.M. Ashlock, and J.A. Levy Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element DNA Cell Biol. 21 2002 581 586
45. C. Svanholm, L. Bandholtz, A. Lobell, and H. Wigzell Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion J. Immunol. Methods 228 1999 121 130
46. H. Sbai, J. Schneider, A.V. Hill, and R.G. Whalen Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization Vaccine 20 2002 3137 3147
47. G. Inchauspe, L. Vitvitski, M.E. Major, G. Jung, U. Spengler, M. Maisonnas, and C. Trepo Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization DNA Cell Biol. 16 1997 185 195
48. P.J. Lewis, G.J. Cox, S. van Drunen Littel-van den Hurk, and L.A. Babiuk Polynucleotide vaccines in animals: enhancing and modulating responses Vaccine 15 1997 861 864
49. J.S. Boyle, C. Koniaras, and A.M. Lew Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization Int. Immunol. 9 1997 1897 1906
50. J. Rice, C.A. King, M.B. Spellerberg, N. Fairweather, and F.K. Stevenson Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines Vaccine 17 1999 3030 3038
51. J.S. Boyle, J.L. Brady, and A.M. Lew Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction Nature 392 1998 408 411
52. A. Aris, J.X. Feliu, A. Knight, C. Coutelle, and A. Villaverde Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression Biotechnol. Bioeng. 68 2000 689 696
53. G. Deliyannis, J.S. Boyle, J.L. Brady, L.E. Brown, and A.M. Lew A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge Proc. Natl. Acad. Sci. U. S. A. 97 2000 6676 6680
54. Y. Wu, X. Wang, K.L. Csencsits, A. Haddad, N. Walters, and D.W. Pascual M cell-targeted DNA vaccination Proc. Natl. Acad. Sci. U. S. A. 98 2001 9318 9323
55. C.F. Hung, W.F. Cheng, K.F. Hsu, C.Y. Chai, L. He, M. Ling, and T.C. Wu Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen Cancer Res. 61 2001 3698 3703
56. Z. You, X. Huang, J. Hester, H.C. Toh, and S.Y. Chen Targeting dendritic cells to enhance DNA vaccine potency Cancer Res. 61 2001 3704 3711
57. F. De Marco, S. Hallez, J.M. Brulet, F. Gesche, P. Marzano, S. Flamini, M.L. Marcante, and A. Venuti DNA vaccines against HPV-16 E7-expressing tumour cells Anticancer Res. 23 2003 1449 1454
58. C.F. Hung, W.F. Cheng, C.Y. Chai, K.F. Hsu, L. He, M. Ling, and T.C. Wu Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen J. Immunol. 166 2001 5733 5740
59. S.C. Oliveira, J.S. Harms, R.R. Afonso, and G.A. Splitter A genetic immunization adjuvant system based on BVP22-antigen fusion Hum. Gene Ther. 12 2001 1353 1359
60. N. Michel, W. Osen, L. Gissmann, T.N. Schumacher, H. Zentgraf, and M. Muller Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination Virology 294 2002 47 59
61. C.F. Hung, L. He, J. Juang, T.J. Lin, M. Ling, and T.C. Wu Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen J. Virol. 76 2002 2676 2682
62. J.A. Leifert, J.A. Lindencrona, J. Charo, and J.L. Whitton Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine Hum. Gene Ther. 12 2001 1881 1892
63. G. Elliott, and P. O'Hare Intercellular trafficking and protein delivery by a herpesvirus structural protein Cell 88 1997 223 233
64. J.A. Leifert, and J.L. Whitton "Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms Molec. Ther. 8 2003 13 20
65. P.O. Falnes, J. Wesche, and S. Olsnes Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment Biochemistry 40 2001 4349 4358
66. M. Lundberg, and M. Johansson Is VP22 nuclear homing an artifact? Nat. Biotechnol. 19 2001 713 714
67. M. Lundberg, and M. Johansson Positively charged DNA-binding proteins cause apparent cell membrane translocation Biochem. Biophys. Res. Commun. 291 2002 367 371
68. M. Lundberg, S. Wikstrom, and M. Johansson Cell surface adherence and endocytosis of protein transduction domains Molec. Ther. 8 2003 143 150
69. T.W. Tobery, and R.F. Siliciano Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization J. Exp. Med. 185 1997 909 920
70. H. Ji, T.L. Wang, C.H. Chen, S.I. Pai, C.F. Hung, K.Y. Lin, R.J. Kurman, D.M. Pardoll, and T.C. Wu Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors Hum. Gene Ther. 10 1999 2727 2740
71. T.C. Wu, F.G. Guarnieri, K.F. Staveley-O'Carroll, R.P. Viscidi, H.I. Levitsky, L. Hedrick, K.R. Cho, J.T. August, and D.M. Pardoll Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens Proc. Natl. Acad. Sci. U. S. A. 92 1995 11671 11675
72. D. Zhu, J. Rice, N. Savelyeva, and F.K. Stevenson DNA fusion vaccines against B-cell tumors Trends Mol. Med. 7 2001 566 572
73. C.A. King, M.B. Spellerberg, D. Zhu, J. Rice, S.S. Sahota, A.R. Thompsett, T.J. Hamblin, J. Radl, and F.K. Stevenson DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma Nat. Med. 4 1998 1281 1286
74. D. Haddad, J. Ramprakash, M. Sedegah, Y. Charoenvit, R. Baumgartner, S. Kumar, S.L. Hoffman, and W.R. Weiss Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles J. Immunol. 165 2000 3772 3781
75. S. Gurunathan, D.M. Klinman, and R.A. Seder DNA vaccines: immunology, application, and optimization* Annu. Rev. Immunol. 18 2000 927 974
76. C.H. Pan, H.W. Chen, and M.H. Tao Modulation of immune responses to DNA vaccines by codelivery of cytokine genes J. Formos. Med. Assoc. 98 1999 722 729
77. M.J. McCluskie, C.L. Brazolot Millan, R.A. Gramzinski, H.L. Robinson, J.C. Santoro, J.T. Fuller, G. Widera, J.R. Haynes, R.H. Purcell, and H.L. Davis Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates Mol. Med. 5 1999 287 300
78. C.J. Pachuk, R.B. Ciccarelli, M. Samuel, M.E. Bayer, R.D. Troutman, D.V. Zurawski, J.I. Schauer, T.J. Higgins, D.B. Weiner, D.M. Sosnoski, V.R. Zurawski, and C. Satishchandran Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine Biochim. Biophys. Acta 1468 2000 20 30
79. K. Kawabata, Y. Takakura, and M. Hashida The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake Pharm. Res. 12 1995 825 830
80. D.C. Tang, M. DeVit, and S.A. Johnston Genetic immunization is a simple method for eliciting an immune response Nature 356 1992 152 154
81. R.G. Webster, E.F. Fynan, J.C. Santoro, and H. Robinson Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin Vaccine 12 1994 1495 1498
82. J. Chinsangaram, C. Beard, P.W. Mason, M.K. Zellner, G. Ward, and M.J. Grubman Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins J. Virol. 72 1998 4454 4457
83. G. Colombage, R. Hall, M. Pavy, and M. Lobigs DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus Virology 250 1998 151 163
84. A.M. Bennett, R.J. Phillpotts, S.D. Perkins, S.C. Jacobs, and E.D. Williamson Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus Vaccine 18 1999 588 596
85. Y. Asakura, P. Lundholm, A. Kjerrstrom, R. Benthin, E. Lucht, J. Fukushima, S. Schwartz, K. Okuda, B. Wahren, and J. Hinkula DNA-plasmids of HIV-1 induce systemic and mucosal immune responses Biol. Chem. 380 1999 375 379
86. A.A. Belperron, D. Feltquate, B.A. Fox, T. Horii, and D.J. Bzik Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum Infect. Immun. 67 1999 5163 5169
87. A. Yoshida, T. Nagata, M. Uchijima, T. Higashi, and Y. Koide Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses Vaccine 18 2000 1725 1729
88. H.S. Garmory, D. Freeman, K.A. Brown, and R.W. Titball Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen Vaccine 22 2004 947 957
89. M.A. Barry, and S.A. Johnston Biological features of genetic immunization Vaccine 15 1997 788 791
90. W.W. Leitner, H. Ying, and N.P. Restifo DNA and RNA-based vaccines: principles, progress and prospects Vaccine 18 1999 765 777
91. S.K. Prayaga, M.J. Ford, and J.R. Haynes Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization Vaccine 15 1997 1349 1352
92. R. Schirmbeck, and J. Reimann Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12 Intervirology 44 2001 115 123
93. V.W. Bramwell, J.E. Eyles, S. Somavarapu, and H.O. Alpar Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen Immunology 106 2002 412 418
94. G. Gregoriadis, R. Saffie, and J.B. de Souza Liposome-mediated DNA vaccination FEBS Lett. 402 1997 107 110
95. K.S. Denis-Mize, M. Dupuis, M.L. MacKichan, M. Singh, B. Doe, D. O'Hagan, J.B. Ulmer, J.J. Donnelly, D.M. McDonald, and G. Ott Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells Gene Ther. 7 2000 2105 2112
96. M. Singh, M. Briones, G. Ott, and D. O'Hagan Cationic microparticles: a potent delivery system for DNA vaccines Proc. Natl. Acad. Sci. U. S. A. 97 2000 811 816
97. D.H. Jones, J.C. Clegg, and G.H. Farrar Oral delivery of micro-encapsulated DNA vaccines Dev. Biol. Stand. 92 1998 149 155
98. U. McKeever, S. Barman, T. Hao, P. Chambers, S. Song, L. Lunsford, Y.Y. Hsu, K. Roy, and M.L. Hedley Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles Vaccine 20 2002 1524 1531
99. D. O'Hagan, M. Singh, M. Ugozzoli, C. Wild, S. Barnett, M. Chen, M. Schaefer, B. Doe, G.R. Otten, and J.B. Ulmer Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines J. Virol. 75 2001 9037 9043
100. Y. Luo, D. O'Hagan, H. Zhou, M. Singh, J. Ulmer, R.A. Reisfeld, F. James Primus, and R. Xiang Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice Vaccine 21 2003 1938 1947
101. S.C. Chen, D.H. Jones, E.F. Fynan, G.H. Farrar, J.C. Clegg, H.B. Greenberg, and J.E. Herrmann Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles J. Virol. 72 1998 5757 5761
102. R.J. Mannino, M. Canki, E. Feketeova, A.J. Scolpino, Z. Wang, F. Zhang, M.T. Kheiri, and S. Gould-Fogerite Targeting immune response induction with cochleate and liposome-based vaccines Adv. Drug Deliv. Rev. 32 1998 273 287
103. D.R. Sizemore, A.A. Branstrom, and J.C. Sadoff Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization Science 270 1995 299 302
104. D.R. Sizemore, A.A. Branstrom, and J.C. Sadoff Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization Vaccine 15 1997 804 807
105. G. Dietrich, A. Bubert, I. Gentschev, Z. Sokolovic, A. Simm, A. Catic, S.H. Kaufmann, J. Hess, A.A. Szalay, and W. Goebel Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes Nat. Biotechnol. 16 1998 181 185
106. C. Grillot-Courvalin, S. Goussard, and P. Courvalin Bacteria as gene delivery vectors for mammalian cells Curr. Opin. Biotechnol. 10 1999 477 481
107. A. Darji, C.A. Guzman, B. Gerstel, P. Wachholz, K.N. Timmis, J. Wehland, T. Chakraborty, and S. Weiss Oral somatic transgene vaccination using attenuated S. typhimurium Cell 91 1997 765 775
108. M.F. Pasetti, R.J. Anderson, F.R. Noriega, M.M. Levine, and M.B. Sztein Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses Clin. Immunol. 92 1999 76 89
109. H.S. Garmory, K.A. Brown, and R.W. Titball Salmonella vaccines for use in humans: present and future perspectives FEMS Microbiol. Rev. 26 2002 339 353
110. A.V. Hill, W. Reece, P. Gothard, V. Moorthy, M. Roberts, K. Flanagan, M. Plebanski, C. Hannan, J.T. Hu, R. Anderson, P. Degano, J. Schneider, E. Prieur, E. Sheu, and S.C. Gilbert DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy Dev. Biol. (Basel) 104 2000 171 179
111. A.L. Devico, T.R. Fouts, M.T. Shata, R. Kamin-Lewis, G.K. Lewis, and D.M. Hone Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1 Vaccine 20 2002 1968 1974
112. D. Haddad, S. Liljeqvist, S. Stahl, M. Hansson, P. Perlmann, N. Ahlborg, and K. Berzins Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol Scand. J. Immunol. 49 1999 506 514
113. J. Schneider, S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, C.M. Hannan, M. Becker, R. Sinden, G.L. Smith, and A.V. Hill Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat. Med. 4 1998 397 402
114. S.J. McConkey, W.H. Reece, V.S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J.M. Vuola, T.J. Blanchard, P. Gothard, K. Watkins, C.M. Hannan, S. Everaere, K. Brown, K.E. Kester, J. Cummings, J. Williams, D.G. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M.T. Roberts, M. Roy, G.L. Smith, J. Schneider, T. Peto, R.E. Sinden, S.C. Gilbert, and A.V. Hill Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat. Med. 9 2003 729 735
115. R.W. Titball, and E.D. Williamson Vaccine development for potential bioterrorism agents Curr. Drug Targets Infect. Disord. 3 2003 255 262
116. H.C. Lane, J.L. Montagne, and A.S. Fauci Bioterrorism: a clear and present danger Nat. Med. 7 2001 1271 1273
117. M. Yokoyama, J. Zhang, and J.L. Whitton DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection J. Virol. 69 1995 2684 2688
118. M.C. Galmiche, J. Goenaga, R. Wittek, and L. Rindisbacher Neutralizing and protective antibodies directed against vaccinia virus envelope antigens Virology 254 1999 71 80
119. J.W. Hooper, D.M. Custer, C.S. Schmaljohn, and A.L. Schmaljohn DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge Virology 266 2000 329 339
120. J.W. Hooper, D.M. Custer, and E. Thompson Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates Virology 306 2003 181 195
121. J. Rice, T. Elliott, S. Buchan, and F.K. Stevenson DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines J. Immunol. 167 2001 1558 1565
122. T.T. Le, D. Drane, J. Malliaros, J.C. Cox, L. Rothel, M. Pearse, T. Woodberry, J. Gardner, and A. Suhrbier Cytotoxic T cell polyepitope vaccines delivered by ISCOMs Vaccine 19 2001 4669 4675
123. J. Riemenschneider, A. Garrison, J. Geisbert, P. Jahrling, M. Hevey, D. Negley, A. Schmaljohn, J. Lee, M.K. Hart, L. Vanderzanden, D. Custer, M. Bray, A. Ruff, B. Ivins, A. Bassett, C. Rossi, and C. Schmaljohn Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus Vaccine 21 2003 4071 4080
124. L. Vanderzanden, M. Bray, D. Fuller, T. Roberts, D. Custer, K. Spik, P. Jahrling, J. Huggins, A. Schmaljohn, and C. Schmaljohn DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge Virology 246 1998 134 144
125. R.J. Phillpotts, K. Venugopal, and T. Brooks Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus Arch. Virol. 141 1996 743 749
126. J.H. Aberle, S.W. Aberle, S.L. Allison, K. Stiasny, M. Ecker, C.W. Mandl, R. Berger, and F.X. Heinz A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms J. Immunol. 163 1999 6756 6761
127. K.I. Kamrud, J.W. Hooper, F. Elgh, and C.S. Schmaljohn Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters Virology 263 1999 209 219
128. E.D. Williamson, A.M. Bennett, S.D. Perkins, R.J. Beedham, J. Miller, and L.W. Baillie Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague Vaccine 20 2002 2933 2941
129. H. Grosfeld, S. Cohen, T. Bino, Y. Flashner, R. Ber, E. Mamroud, C. Kronman, A. Shafferman, and B. Velan Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen Infect. Immun. 71 2003 374 383
130. P. Brandler, K.U. Saikh, D. Heath, A. Friedlander, and R.G. Ulrich Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive J. Immunol. 161 1998 4195 4200
131. R. Gaur, P.K. Gupta, A.C. Banerjea, and Y. Singh Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin Vaccine 20 2002 2836 2839
132. S.N. Tucker, K. Lin, S. Stevens, R. Scollay, M.J. Bennett, and D.C. Olson Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland Molec. Ther. 8 2003 392 399
133. M.L. Gu, S.H. Leppla, and D.M. Klinman Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen Vaccine 17 1999 340 344
134. B.M. Price, A.L. Liner, S. Park, S.H. Leppla, A. Mateczun, and D.R. Galloway Protection against anthrax lethal toxin challenge by genetic immunisation with a plasmid encoding the lethal factor protein Infect. Immun. 2001 4509 4515
135. S.E. Leary, E.D. Williamson, K.F. Griffin, P. Russell, S.M. Eley, and R.W. Titball Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague Infect. Immun. 63 1995 2854 2858
136. G.P. Andrews, D.G. Heath, G.W. Anderson Jr., S.L. Welkos, and A.M. Friedlander Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge Infect. Immun. 64 1996 2180 2187
137. E.D. Williamson, P.M. Vesey, K.J. Gillhespy, S.M. Eley, M. Green, and R.W. Titball An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model Clin. Exp. Immunol. 116 1999 107 114
138. C.C. Winter, W.B. Cherry, and M.D. Moody An unusual strain of Pasteurella pestis isolated from a fatal human case of plague Bull. World Health Organ 23 1960 408 409
139. B.W. McBride, A. Mogg, J.L. Telfer, M.S. Lever, J. Miller, P.C. Turnbull, and L. Baillie Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers Vaccine 16 1998 810 817
140. J. Miller, B.W. McBride, R.J. Manchee, P. Moore, and L.W. Baillie Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis Lett. Appl. Microbiol. 26 1998 56 60
141. G.B. Altman Tularemia. A pathogen in nature and a biological weapon AAOHN J. 50 2002 373 377 (quiz 378-379)
142. K.M. Lima, V.L. Bonato, L.H. Faccioli, I.T. Brandao, S.A. dos Santos, A.A. Coelho-Castelo, S.C. Leao, and C.L. Silva Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice Vaccine 19 2001 3518 3525
143. H.M. Vordermeier, D.B. Lowrie, and R.G. Hewinson Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting Vet. Microbiol. 93 2003 349 359
144. G. Delogu, A. Li, C. Repique, F. Collins, and S.L. Morris DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis Infect. Immun. 70 2002 292 302
145. J.A. Triccas, L. Sun, U. Palendira, and W.J. Britton Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis Immunol. Cell Biol. 80 2002 346 350
146. E. Martin, A.T. Kamath, H. Briscoe, and W.J. Britton The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guerin) in protecting against systemic Mycobacterim avium infection Immunology 109 2003 308 314
147. R.H. Shyu, M.F. Shaio, S.S. Tang, H.F. Shyu, C.F. Lee, M.H. Tsai, J.E. Smith, H.H. Huang, J.J. Wey, J.L. Huang, and H.H. Chang DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice J. Biomed. Sci. 7 2000 51 57
148. J. Clayton, and J.L. Middlebrook Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A Vaccine 18 2000 1855 1862
149. A.M. Bennett, S.D. Perkins, and J.L. Holley DNA vaccination protects against botulinum neurotoxin type F Vaccine 21 2003 3110 3117
150. J. Donnelly, K. Berry, and J.B. Ulmer Technical and regulatory hurdles for DNA vaccines Int. J. Parasitol. 33 2003 457 467
151. B.J. Ledwith, S. Manam, P.J. Troilo, A.B. Barnum, C.J. Pauley, T.G. Griffiths 2nd, L.B. Harper, H.B. Schock, H. Zhang, J.E. Faris, P.A. Way, C.M. Beare, W.J. Bagdon, and W.W. Nichols Plasmid DNA vaccines: assay for integration into host genomic DNA Dev. Biol. (Basel) 104 2000 33 43
152. E. Griffiths Assuring the safety and efficacy of DNA vaccines Ann. N.Y. Acad. Sci. 772 1995 164 169
153. B.D. Livingston, M. Newman, C. Crimi, D. McKinney, R. Chesnut, and A. Sette Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines Vaccine 19 2001 4652 4660
154. G.N. Ferreira, G.A. Monteiro, D.M. Prazeres, and J.M. Cabral Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications Trends Biotechnol. 18 2000 380 388